BHCM
MRTX

Boulder Hill Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Boulder Hill Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,900
Closed -$572K – 259
2021
Q4 		$572K Buy
+3,900
New +$572K 0.55% 60